Two Private Research Institutes in Tsukuba to Close
A report in the Nikkei claims GlaxoSmithKline (GSK) will follow Pfizer’s example and close its research base in Tsukuba, relocating the 100 scientists employed there to the development division of its Japanese subsidiary. The move could happen as soon as this summer, according to the paper. According to the report, the pharma heavyweight hopes that the move will allow it to accelerate its clinical trials and the commercialisation of new products.
Read the full article: Sun setting on big pharma research in Japan?